Scientific Articles

Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047

Hussein A. Tawbi, MD, PhD, F. Stephen Hodi, MD, Evan J. Lipson, MD, Dirk Schadendorf, MD, Paolo A. Ascierto, MD, Luis Matamala, MD, Erika Castillo Gutiérrez, MD, Piotr Rutkowski, MD, Helen Gogas, MD, Christopher D. Lao, MD, MPH, Juliana Janoski De Menezes, MD, Stéphane Dalle, MD, PhD, Ana Maria Arance, MD, PhD, Jean-Jacques Grob, MD, Barbara Ratto, MD, MSc, Saima Rodriguez, MD, Antonella Mazzei, PhD, Sonia Dolfi, PhD, and Georgina V. Long, MD, PhD

Journal of Clinical Oncology

Abstract link